PT1828151E - Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer - Google Patents
Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer Download PDFInfo
- Publication number
- PT1828151E PT1828151E PT05811672T PT05811672T PT1828151E PT 1828151 E PT1828151 E PT 1828151E PT 05811672 T PT05811672 T PT 05811672T PT 05811672 T PT05811672 T PT 05811672T PT 1828151 E PT1828151 E PT 1828151E
- Authority
- PT
- Portugal
- Prior art keywords
- secretase
- alzheimer
- gamma
- inhibitors
- disease
- Prior art date
Links
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 title 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- WRIRWRKPLXCTFD-UHFFFAOYSA-N malonamide Chemical class NC(=O)CC(N)=O WRIRWRKPLXCTFD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04106395 | 2004-12-08 | ||
| EP05100816 | 2005-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1828151E true PT1828151E (pt) | 2011-06-16 |
Family
ID=36293585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05811672T PT1828151E (pt) | 2004-12-08 | 2005-12-01 | Derivados de malonamida como inibidores de gama-secretase para o tratamento da doença de alzheimer |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7211573B2 (pt) |
| EP (1) | EP1828151B1 (pt) |
| JP (1) | JP4979590B2 (pt) |
| KR (1) | KR100890678B1 (pt) |
| CN (1) | CN101072760B (pt) |
| AR (1) | AR053987A1 (pt) |
| AT (1) | ATE504580T1 (pt) |
| AU (1) | AU2005313582B8 (pt) |
| BR (1) | BRPI0518615A2 (pt) |
| CA (1) | CA2589196A1 (pt) |
| DE (1) | DE602005027388D1 (pt) |
| DK (1) | DK1828151T3 (pt) |
| IL (1) | IL183293A0 (pt) |
| MX (1) | MX2007006504A (pt) |
| NO (1) | NO20072609L (pt) |
| NZ (1) | NZ555184A (pt) |
| PL (1) | PL1828151T3 (pt) |
| PT (1) | PT1828151E (pt) |
| RU (1) | RU2402538C2 (pt) |
| TW (1) | TWI349005B (pt) |
| WO (1) | WO2006061136A2 (pt) |
| ZA (1) | ZA200705018B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0717587A2 (pt) * | 2006-09-20 | 2013-10-29 | Hoffmann La Roche | Derivados de 4-oxo-2,3,4,5-tetra-hidro-benzo[b][1,4]diazepina |
| BRPI0807341A2 (pt) | 2007-02-02 | 2014-05-20 | Hoffmann La Roche | Derivados de 6-oxo-6,7-di-hidro-5h-dibenzo[b,d]azepin-7-ila |
| RU2010133489A (ru) * | 2008-01-11 | 2012-02-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Применение ингибиторов гамма-секретазы для лечения рака |
| US8741889B2 (en) * | 2008-01-11 | 2014-06-03 | Hoffmann-La Roche Inc | Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor |
| CN107438599B (zh) * | 2015-06-11 | 2021-12-10 | 豪夫迈·罗氏有限公司 | 靶向Notch通路抑制剂 |
| EP3700904B1 (en) | 2017-10-24 | 2023-07-19 | Bayer AG | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| KR20250119653A (ko) | 2018-11-07 | 2025-08-07 | 추가이 세이야쿠 가부시키가이샤 | O-치환 세린 유도체의 제조 방법 |
| PH12021552693A1 (en) | 2019-04-24 | 2022-03-21 | Bayer Ag | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| WO2020216774A1 (en) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one derivatives |
| CA3137610A1 (en) | 2019-04-24 | 2020-10-29 | Bayer Aktiengesellschaft | 4h-pyrrolo[3,2-c]pyridin-4-one compounds |
| CN112300019A (zh) * | 2019-07-31 | 2021-02-02 | 华东师范大学 | 一种邻乙酰氨基苯丁酸类化合物的制备方法 |
| EP4126861B1 (en) | 2020-03-31 | 2025-06-18 | Bayer Aktiengesellschaft | 3-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancer |
| KR20230155446A (ko) | 2021-03-09 | 2023-11-10 | 바스프 에스이 | 말론아미드 및 제초제로서의 그의 용도 |
| EP4391808A1 (en) * | 2021-08-25 | 2024-07-03 | Basf Se | Herbicidal malonamides |
| AU2022339008A1 (en) * | 2021-08-31 | 2024-03-14 | Basf Se | Herbicidal malonamides containing a condensed ring system |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL72523A (en) * | 1983-08-12 | 1988-06-30 | Takeda Chemical Industries Ltd | 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them |
| JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
| AU4707999A (en) * | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
| GB0012671D0 (en) | 2000-05-24 | 2000-07-19 | Merck Sharp & Dohme | Therapeutic agents |
| ATE430726T1 (de) * | 2002-05-29 | 2009-05-15 | Hoffmann La Roche | N-acylamino-benzyletherderivate als selektive inhibitoren der monoaminoxidase b |
| TW200502221A (en) * | 2002-10-03 | 2005-01-16 | Astrazeneca Ab | Novel lactams and uses thereof |
| EP1592684B1 (en) | 2003-02-04 | 2008-07-30 | F. Hoffmann-La Roche Ag | Malonamide derivatives as gamma-secretase inhibitors |
| US7060698B2 (en) | 2003-05-19 | 2006-06-13 | Hoffmann-La Roche Inc. | Benzoxazepinone derivatives |
| KR100838852B1 (ko) | 2003-09-09 | 2008-06-16 | 에프. 호프만-라 로슈 아게 | 감마-세크리테이즈의 활성을 차단하는 말론아미드 유도체 |
| AU2004283803B2 (en) | 2003-10-06 | 2010-06-24 | F. Hoffmann-La Roche Ag | Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
-
2005
- 2005-11-30 US US11/289,176 patent/US7211573B2/en not_active Expired - Fee Related
- 2005-12-01 BR BRPI0518615-3A patent/BRPI0518615A2/pt not_active IP Right Cessation
- 2005-12-01 CA CA002589196A patent/CA2589196A1/en not_active Abandoned
- 2005-12-01 RU RU2007120211/04A patent/RU2402538C2/ru not_active IP Right Cessation
- 2005-12-01 PT PT05811672T patent/PT1828151E/pt unknown
- 2005-12-01 DE DE602005027388T patent/DE602005027388D1/de not_active Expired - Lifetime
- 2005-12-01 AT AT05811672T patent/ATE504580T1/de active
- 2005-12-01 PL PL05811672T patent/PL1828151T3/pl unknown
- 2005-12-01 AU AU2005313582A patent/AU2005313582B8/en not_active Ceased
- 2005-12-01 EP EP05811672A patent/EP1828151B1/en not_active Expired - Lifetime
- 2005-12-01 JP JP2007544779A patent/JP4979590B2/ja not_active Expired - Fee Related
- 2005-12-01 MX MX2007006504A patent/MX2007006504A/es active IP Right Grant
- 2005-12-01 NZ NZ555184A patent/NZ555184A/en not_active IP Right Cessation
- 2005-12-01 CN CN2005800421635A patent/CN101072760B/zh not_active Expired - Fee Related
- 2005-12-01 KR KR1020077015604A patent/KR100890678B1/ko not_active Expired - Fee Related
- 2005-12-01 DK DK05811672.4T patent/DK1828151T3/da active
- 2005-12-01 WO PCT/EP2005/012834 patent/WO2006061136A2/en not_active Ceased
- 2005-12-07 AR ARP050105106A patent/AR053987A1/es unknown
- 2005-12-07 TW TW094143269A patent/TWI349005B/zh not_active IP Right Cessation
-
2007
- 2007-05-17 IL IL183293A patent/IL183293A0/en unknown
- 2007-05-24 NO NO20072609A patent/NO20072609L/no not_active Application Discontinuation
- 2007-06-04 ZA ZA200705018A patent/ZA200705018B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR053987A1 (es) | 2007-05-30 |
| MX2007006504A (es) | 2007-06-22 |
| ATE504580T1 (de) | 2011-04-15 |
| AU2005313582B2 (en) | 2011-06-02 |
| PL1828151T3 (pl) | 2011-09-30 |
| CN101072760B (zh) | 2011-12-28 |
| AU2005313582A8 (en) | 2011-06-16 |
| US7211573B2 (en) | 2007-05-01 |
| EP1828151A2 (en) | 2007-09-05 |
| EP1828151B1 (en) | 2011-04-06 |
| AU2005313582B8 (en) | 2011-06-16 |
| US20060122168A1 (en) | 2006-06-08 |
| WO2006061136A2 (en) | 2006-06-15 |
| ZA200705018B (en) | 2010-04-28 |
| DK1828151T3 (da) | 2011-05-16 |
| IL183293A0 (en) | 2007-09-20 |
| BRPI0518615A2 (pt) | 2008-11-25 |
| DE602005027388D1 (de) | 2011-05-19 |
| TWI349005B (en) | 2011-09-21 |
| KR20070086979A (ko) | 2007-08-27 |
| WO2006061136A3 (en) | 2006-08-03 |
| JP4979590B2 (ja) | 2012-07-18 |
| KR100890678B1 (ko) | 2009-03-26 |
| NZ555184A (en) | 2010-01-29 |
| RU2007120211A (ru) | 2009-01-20 |
| CN101072760A (zh) | 2007-11-14 |
| AU2005313582A1 (en) | 2006-06-15 |
| RU2402538C2 (ru) | 2010-10-27 |
| JP2008522994A (ja) | 2008-07-03 |
| NO20072609L (no) | 2007-06-19 |
| CA2589196A1 (en) | 2006-06-15 |
| TW200626568A (en) | 2006-08-01 |
| HK1114840A1 (en) | 2008-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200705018B (en) | Malonamide derivatives as inhibitors of gamma-secretase for the treatment of Alzheimer's disease | |
| ZA200706791B (en) | Isoxazole combretasin derivatives for the treatment of disorders | |
| IL208350A0 (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
| ZA200707531B (en) | N-(N-Sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain | |
| HUS1500034I1 (hu) | Indolidon-származékok fibrózisos betegségek kezelésére vagy megelõzésére | |
| ZA200907137B (en) | Novel N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
| ZA200809857B (en) | Terphenyl derivatives for treatment of alzheimer's disease | |
| IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
| IL177232A0 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| IL186022A0 (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
| IL192933A0 (en) | Benzoisoindole derivatives for the treatment of pain | |
| IL188449A0 (en) | Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for the treatment of cardiovascular disease | |
| IL172018A0 (en) | Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| EP1750698A4 (en) | 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES | |
| PL1959957T3 (pl) | Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości | |
| AU2008339005A8 (en) | 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of Alzheimer's disease | |
| GB0620695D0 (en) | Composition and methods for the treatment of nurdegenerative disease | |
| EP2099476A4 (en) | METHODS OF TREATING ALZHEIMER'S DISEASE | |
| ZA200708279B (en) | Dermatological compositions and salts for the treatment of dermatological diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| ZA200608015B (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
| HK1149932A (en) | Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease | |
| HK1141791A (en) | Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
| AP2006003743A0 (en) | Compounds useful for the treatment of diseases |